Catherine Lindgren
- Oncology top 1%
- Immunology top 2%
- Genetics top 2%
- Molecular Biology
- Biomedical Engineering top 5%
- Co-authors
- Michael C. JensenStanley R. RiddellOliver W. PressPhilip D. GreenbergAndrew RaubitschekJinjuan WangStephen J. FormanXiaojun Qian
- Topics
- CAR-T cell therapy research (25 papers)Immune Cell Function and Interaction (14 papers)Immunotherapy and Immune Responses (10 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Catherine Lindgren
40 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 2.5k
- Immunology 1.1k
- Genetics 801
- Molecular Biology 691
- Biomedical Engineering 643
Countries citing papers authored by Catherine Lindgren
This map shows the geographic impact of Catherine Lindgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Lindgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Lindgren more than expected).
Fields of papers citing papers by Catherine Lindgren
This network shows the impact of papers produced by Catherine Lindgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Lindgren. The network helps show where Catherine Lindgren may publish in the future.
Co-authorship network of co-authors of Catherine Lindgren
This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Lindgren. A scholar is included among the top collaborators of Catherine Lindgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Lindgren. Catherine Lindgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 14 | |
| 4 | 6 | |
| 5 | 16 | |
| 6 | 10 | |
| 7 | 71 | |
| 8 | 31 | |
| 9 | CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsbreakdown → | 431 |
| 10 | Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsbreakdown → | 573 |
| 11 | 177 | |
| 12 | 73 | |
| 13 | 33 | |
| 14 | Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies. | 16 |
| 15 | Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial. | 53 |
| 16 | 19 | |
| 17 | 4 | |
| 18 | 4 | |
| 19 | 53 | |
| 20 | Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells. | 63 |
About Catherine Lindgren
Catherine Lindgren is a scholar working on Oncology, Immunology and Hematology, having authored 40 papers that have together received 2.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (25 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (10 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.1k citations) and Genetics (801 citations). Catherine Lindgren has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Michael C. Jensen, Stanley R. Riddell, Oliver W. Press, Philip D. Greenberg, Andrew Raubitschek, Jinjuan Wang, Stephen J. Forman, Xiaojun Qian, Brian G. Till and Julie R. Park. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.